Outcomes in Patients Receiving Treatment for Pulmonary Arterial Hypertension Associated With Repaired Congenital Heart Disease

By sjmartinez • February 26, 2025

Krasuski RA, Tobore T, Studer S, Jansa P, Sitbon O, Hoeper MM, Channick R, Gaine S, Lang I, Chin K, Pulido T, Mehta S, Torbicki A, Sastry B, Tang X, McLaughlin V, Reardon LC. Outcomes in Patients Receiving Treatment for Pulmonary Arterial Hypertension Associated With Repaired Congenital Heart Disease. JACC Adv. 2025 Feb 24;4(3):101626. doi: 10.1016/j.jacadv.2025.101626. Epub ahead of print. PMID: 39999520.

Tags: Cardiology/Epi, COMPASS-2, congenital heart disease, GRIPHON, Pooled analysis, Publications, pulmonary arterial hypertension, Pulmonary, Critical Care & Sleep Medicine, SERAPHIN

Ventricular Repolarization in Healthy Young Adults Who Use Combusted Cannabis: A Cross-Sectional Parallel Group Comparison Study

Hampilos K, Fong R, Sanchez J, Ruedisueli I, Lopez S, Zhao K, Gornbein J, Cooper ZD, Middlekauff H. Ventricular Repolarization in Healthy Young Adults Who[...]

The 2018 World Cancer Research Fund /American Institute for Cancer Research Score and Cancer Risk: Results from the Diabetes Prevention Program Outcomes Study

Tjaden AH, Goldbaum AA, Edelstein SL, Heckman-Stoddard BM, Reedy J, Herman WH, Hoskin M, Knowler WC, Schlögl M, Temple KA, Venditti EM, Watson K, Temprosa[...]

Mortality trends related to cardiogenic shock in heart failure patients aged 25 and older across the United States: A study utilizing the CDC WONDER database from 1999 to 2023

Muhammad AN, Neppala S, Chigurupati HD, Rehan MO, Naveed H, Iqbal R, Azeem B, Ali A, Ahmed M, Upreti P, Haider MZ, Sattar Y, Rana[...]